Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

Alabama

CNS trials open to children and teens in Alabama

16 CNS studies open to children and teens are recruiting participants at sites in 4 cities across Alabama as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Alabama by city

Cities with the most studies recruiting right now.

Every Alabama city with a recruiting study

By research area: Depression (4), Migraine (4), ADHD (3), Epilepsy (3), Schizophrenia (2).

Birmingham (7), Dothan (5), Huntsville (4), Saraland (3).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

ADHD: recently updated in Alabama

Basic details from each study's public record (the 12 most recently updated of 16). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

    • Phase 3
    • Ages 6 to 11
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    Dothan
    Registry record
    NCT07717879 · updated
  2. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    Dothan
    Registry record
    NCT07717892 · updated
  3. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

    • Phase 4
    • From 48 months, up to 69 months
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Saraland
    Registry record
    NCT04781140 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Alabama on ClinicalTrials.gov.

Depression: recently updated in Alabama

  1. Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

    • No phase
    • Ages 12 to 22
    • All sexes
    Sponsor
    Michigan State University
    Recruiting in
    Birmingham
    Registry record
    NCT06232304 · updated
  2. Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Recruiting in
    Dothan
    Registry record
    NCT06372964 · updated
  3. A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Birmingham
    Registry record
    NCT07227454 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Alabama on ClinicalTrials.gov.

Epilepsy: recently updated in Alabama

  1. Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES

    • No phase
    • Ages 11 to 18
    • All sexes
    Sponsor
    University of Alabama at Birmingham
    Recruiting in
    Birmingham
    Registry record
    NCT05096273 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Alabama on ClinicalTrials.gov.

Migraine: recently updated in Alabama

  1. A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Huntsville
    Registry record
    NCT06810505 · updated
  2. A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Huntsville · Saraland
    Registry record
    NCT05711394 · updated
  3. Responding With Evidence and Access for Childhood Headaches

    • No phase
    • Ages 10 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Recruiting in
    Birmingham
    Registry record
    NCT05889624 · updated
  4. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Huntsville · Saraland
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Alabama on ClinicalTrials.gov.

Schizophrenia: recently updated in Alabama

  1. Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

    • Phase 4
    • Ages 12 to 17
    • All sexes
    Sponsor
    Vanda Pharmaceuticals
    Recruiting in
    Dothan
    Registry record
    NCT05648591 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Alabama on ClinicalTrials.gov.

Ask about studies in Alabama

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call